Budget Impact Analysis of the Introduction of a Trastuzumab Biosimilar for HER2-Positive Breast Cancer in China
Year: 2022
Type: article
Source: Clinical Drug Investigation
Authors: Qingqing Chai, Haini Wen, Yitian Lang, Lingyu Zhang, Yan Song, Xiaoyan Liu
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4296139527
